Logo-jcvtr

Read This Article

Article History

Submitted: 09 Nov 2025
Revision: 10 Dec 2025
Accepted: 13 Dec 2025
ePublished: 17 Dec 2025

  Google Scholar Profile

PubMed Profile

Share This Article!

Export Citation

EndNote EndNote

(Enw Format - Win & Mac)

BibTeX BibTeX

(Bib Format - Win & Mac)

Bookends Bookends

(Ris Format - Mac only)

EasyBib EasyBib

(Ris Format - Win & Mac)

Medlars Medlars

(Txt Format - Win & Mac)

Mendeley Web Mendeley Web
Mendeley Mendeley

(Ris Format - Win & Mac)

Papers Papers

(Ris Format - Win & Mac)

ProCite ProCite

(Ris Format - Win & Mac)

Reference Manager Reference Manager

(Ris Format - Win only)

Refworks Refworks

(Refworks Format - Win & Mac)

Zotero Zotero

(Ris Format - Firefox Plugin)

Cited By

J Cardiovasc Thorac Res. 2025;17(4): 215-217.
doi: 10.34172/jcvtr.025.33793
  Abstract View: 109
  PDF Download: 102

Editorial

The cardiovascular safety of GLP-1 receptor agonists: From glucose control to cardiometabolic protection

Samad Ghaffari 1 ORCID logo, Seyedeh-Tarlan Mirzohreh 1 ORCID logo, Neda Roshanravan 1* ORCID logo, Faezeh Tarighat 1* ORCID logo

1 Cardiovascular Research Center, Tabriz University of Medical Sciences, Tabriz, Iran
*Corresponding Authors: Neda Roshanravan, Email: neda.roshanravan10@gmail.com; Faezeh Tarighat, Email: faezehtarighat@gmail.com
First Name
Last Name
Email Address
Comments
Security code


Abstract View: 110

Your browser does not support the canvas element.

PDF Download: 102

Your browser does not support the canvas element.